New hope for ovarian cancer? experimental drug IMGN151 enters Mid-Stage trials
NCT ID NCT07024784
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times
Summary
This study tests an experimental drug called IMGN151 for people with gynecologic cancers, including ovarian cancer. The drug is given alone or with other cancer treatments to see if it is safe and works. About 377 adults will take part at sites worldwide. The goal is to find better ways to control these cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Holy Name Medical Center /ID# 279017
RECRUITINGTeaneck, New Jersey, 07666, United States
-
Hyogo Cancer Center /ID# 276940
RECRUITINGAkashi-shi, Hyōgo, 673-8558, Japan
-
National Cancer Center Hospital /ID# 276715
RECRUITINGChuo-Ku, Tokyo, 104-0045, Japan
-
Next Virginia /ID# 279684
RECRUITINGFairfax, Virginia, 22031, United States
-
Providence Portland Medical Center /ID# 277727
RECRUITINGPortland, Oregon, 97213, United States
-
Rabin Medical Center /ID# 279142
RECRUITINGPetah Tikva, Central District, 4941492, Israel
-
Rambam Health Care Campus- Haifa /ID# 276004
RECRUITINGHaifa, 3525408, Israel
-
SCRI Oncology Partners /ID# 279733
RECRUITINGNashville, Tennessee, 37203, United States
-
Shaare Zedek Medical Center /ID# 275854
RECRUITINGJerusalem, 9103102, Israel
-
Tel Aviv Sourasky Medical Center /ID# 275852
RECRUITINGTel Aviv, Tel Aviv, 6423906, Israel
-
Texas Oncology-Austin North /ID# 279958
RECRUITINGAustin, Texas, 78758, United States
-
The Cancer Institute Hospital Of JFCR /ID# 276711
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
-
The Chaim Sheba Medical Center /ID# 275997
RECRUITINGRamat Gan, Tel Aviv, 5265601, Israel
-
Women & Infants Hospital /ID# 277930
RECRUITINGProvidence, Rhode Island, 02905, United States
Conditions
Explore the condition pages connected to this study.